The dysregulation of pathways, such as Wnt, FGF, SHH, Notch, EGFR, and BMP, can predispose individuals to breast cancer by promoting abnormal cell proliferation, survival, and tissue remodeling. This evidence concerns the gene EGFR and breast cancer.